Integra LifeSciences Forecasts Q1 Fiscal Year 2024 Adjusted EPS Of $0.53-$0.57. Versus Consensus Of $0.75
Portfolio Pulse from Benzinga Newsdesk
Integra LifeSciences has projected its Q1 FY2024 adjusted EPS to be in the range of $0.53-$0.57, which is below the consensus estimate of $0.75.
February 28, 2024 | 11:10 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Integra LifeSciences' projected Q1 FY2024 adjusted EPS significantly misses consensus estimates, indicating potential short-term negative impact on stock.
The projected earnings per share (EPS) for Integra LifeSciences for Q1 FY2024 are significantly below the consensus estimates. This discrepancy typically leads to negative investor sentiment and could result in a short-term decrease in the stock price. The direct mention of the company and the specific financial forecast make this news highly relevant and important for investors in IART.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100